| 1 | PARK25, SNCAIP |
| Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients. | |
| Keyser RJ, Oppon E, Carr JA, Bardien S. | |
| J Neural Transm 118(6):889-97. Epub 2011 Feb 23. 2011 | |
| 2 | PARK25, SNCAIP |
| alpha-Synuclein and Parkinson disease susceptibility. | |
| Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C. | |
| Neurology 69(18):1745-50. Epub 2007 Sep 13. 2007 | |
| 3 | PARK25, SNCAIP |
| Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. | |
| Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. | |
| JAMA 296(6):661-70. 2006 | |
| 4 | PARK12, PARK25 |
| Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. | |
| Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T. | |
| Am J Hum Genet 71(1):124-35. 2002 | |